AVITA Medical Inc (51KB) - Total Assets
Based on the latest financial reports, AVITA Medical Inc (51KB) holds total assets worth €69.56 Million EUR (≈ $81.32 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AVITA Medical Inc balance sheet quality to measure how much of total assets are equity-financed.
AVITA Medical Inc - Total Assets Trend (2019–2024)
This chart illustrates how AVITA Medical Inc's total assets have evolved over time, based on quarterly financial data. Explore AVITA Medical Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
AVITA Medical Inc - Asset Composition Analysis
Current Asset Composition (June 2024)
AVITA Medical Inc's total assets of €69.56 Million consist of 93.2% current assets and 6.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 19.8% |
| Accounts Receivable | €7.66 Million | 6.9% |
| Inventory | €5.60 Million | 5.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €487.00K | 0.4% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how AVITA Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is AVITA Medical Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AVITA Medical Inc's current assets represent 93.2% of total assets in 2024, a decrease from 94.1% in 2019.
- Cash Position: Cash and equivalents constituted 19.8% of total assets in 2024, down from 78.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 6.9% of total assets.
AVITA Medical Inc Competitors by Total Assets
Key competitors of AVITA Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
AVITA Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.09 | 7.25 | 13.77 |
| Quick Ratio | 1.72 | 6.64 | 13.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €25.01 Million | €74.12 Million | €90.08 Million |
AVITA Medical Inc - Advanced Valuation Insights
This section examines the relationship between AVITA Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.29 |
| Latest Market Cap to Assets Ratio | 1.55 |
| Asset Growth Rate (YoY) | 13.6% |
| Total Assets | €111.64 Million |
| Market Capitalization | $172.49 Million USD |
Valuation Analysis
Above Book Valuation: The market values AVITA Medical Inc's assets above their book value (1.55x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: AVITA Medical Inc's assets grew by 13.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AVITA Medical Inc (2019–2024)
The table below shows the annual total assets of AVITA Medical Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €111.64 Million ≈ $130.52 Million |
+13.61% |
| 2023-06-30 | €98.26 Million ≈ $114.88 Million |
-21.70% |
| 2021-06-30 | €125.50 Million ≈ $146.72 Million |
+52.19% |
| 2020-06-30 | €82.46 Million ≈ $96.41 Million |
+220.50% |
| 2019-06-30 | €25.73 Million ≈ $30.08 Million |
-- |
About AVITA Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more